MDT

84.21

-0.14%↓

VEEV

226.67

-0.19%↓

A

106.17

-0.03%↓

WBA

11

-0.09%↓

CHE

555.99

+0.34%↑

MDT

84.21

-0.14%↓

VEEV

226.67

-0.19%↓

A

106.17

-0.03%↓

WBA

11

-0.09%↓

CHE

555.99

+0.34%↑

MDT

84.21

-0.14%↓

VEEV

226.67

-0.19%↓

A

106.17

-0.03%↓

WBA

11

-0.09%↓

CHE

555.99

+0.34%↑

MDT

84.21

-0.14%↓

VEEV

226.67

-0.19%↓

A

106.17

-0.03%↓

WBA

11

-0.09%↓

CHE

555.99

+0.34%↑

MDT

84.21

-0.14%↓

VEEV

226.67

-0.19%↓

A

106.17

-0.03%↓

WBA

11

-0.09%↓

CHE

555.99

+0.34%↑

Search

DaVita Inc

Abrir

SetorSaúde

138.54 -0.67

Visão Geral

Variação de preço das ações

24h

Atual

Mín

137.18

Máximo

140.56

Indicadores-chave

By Trading Economics

Rendimento

135M

349M

Vendas

35M

3.3B

P/E

Médio do Setor

12.442

57.333

EPS

2.24

Margem de lucro

10.6

Funcionários

76,000

EBITDA

8.4M

727M

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+23.24% upside

Dividendos

By Dow Jones

Próximos Ganhos

1 de mai. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-3.3B

11B

Abertura anterior

139.21

Fecho anterior

138.54

Pontuação Técnica

By Trading Central

Confiança

Bearish Evidence

DaVita Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

14 de fev. de 2025, 19:50 UTC

Grandes Movimentos do Mercado

DaVita Stock Declines After Outlook Miss, Berkshire Hathaway Sales

21 de mar. de 2025, 08:19 UTC

Conversa de Mercado

Fresenius Medical Care's Revenue Estimates Lowered by Jefferies on U.S. Volume Concerns -- Market Talk

15 de jul. de 2024, 08:17 UTC

Conversa de Mercado

Fresenius Medical Care, DaVita Brace for Competition, Shift to Home Dialysis -- Market Talk

Comparação entre Pares

Variação de preço

DaVita Inc Previsão

Preço-alvo

By TipRanks

23.24% parte superior

Previsão para 12 meses

Média 172 USD  23.24%

Máximo 184 USD

Mínimo 165 USD

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para DaVita Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

4 ratings

0

Comprar

4

Manter

0

Vender

Pontuação Técnica

By Trading Central

134.97 / 141.35Suporte e Resistência

Curto Prazo

Bearish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

Bearish Evidence

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre DaVita Inc

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.